GAPDH and heart failure: Heart failure was also associated with promoter hypomethylation of enriched glycolytic pathways and anaerobic metabolic processes, including phosphofructokinase (PFKL and PFKP), enolase (ENO1, ENO2, and ENO3), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [24].